If the deal doesn't go through then they may not keep the lights on. I can't see them going to market being able to raise sufficient cash to see them through to production. Either Amgen does a deal or if that falls over, another Pharma steps up but the terms will be less favourable than what Amgen are proposing or they fold. That's my take on it.
77
- Forums
- ASX - By Stock
- UNS
- UNIS in Nasdaq
UNIS in Nasdaq, page-126
-
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)